Icarus Medical has secured an oversubscribed $7.2 million Series A financing round to accelerate commercialization and development of its orthopedic bracing technologies.
The Charlottesville-based medtech company develops advanced braces using biomechanics, additive manufacturing, and patient-focused design to help improve mobility and reduce pain. Its flagship Ascender Knee Brace is designed for patients with patellofemoral and multicompartment knee osteoarthritis through adjustable unloading and extension assistance.
Related: Wise closes $34.8M Series D to support neurostim tech
The funding will support U.S. market expansion, product development, manufacturing growth, clinical validation, and team expansion. Investors include Riptide Ventures, OSF Ventures, CU Healthcare Innovation Fund, Highpoint Ventures, MedTech Connect, Neovate Capital Partners, and BLU Venture Investors.
Icarus Medical CEO Dave Johnson said:
“This financing represents a major milestone for Icarus Medical and validates both the clinical impact of our technology and the strength of the team we have built.”
The investment marks a key growth phase for Icarus as it expands access to its orthopedic solutions and builds its presence in the U.S. healthcare market.
